Howard Slayen sells 25,000 AEHR shares (NASDAQ: AEHR)

Rhea-AI Filing Summary

AEHR insider Howard Slayen reported the sale of 25,000 shares of Common Stock on 04/17/2026, with aggregate proceeds of $2,125,000.00.

The filing also lists multiple prior restricted stock vesting events with small lot sizes between 01/27/2024 and 04/27/2025; these vesting entries are disclosure items and are shown for context.

Insights

Insider Transactions Analyst

Large single-block sale disclosed by an AEHR insider.

The report shows a 25,000-share disposition by Howard Slayen on 04/17/2026 for $2,125,000. This is a direct sale event recorded under the Form 144 disclosure rules and is presented as a completed transaction.

Context entries list recurring Restricted Stock Vesting dates and small share lots across 2024–2025. Timing, motivations, and any trading-plan status are not provided in the excerpt.

Key Figures

Shares sold: 25,000 shares Aggregate proceeds: $2,125,000.00 Restricted stock vesting lot: 558 shares +2 more

5 metrics

Shares sold 25,000 shares sale on 04/17/2026

Aggregate proceeds $2,125,000.00 proceeds from sale on 04/17/2026

Restricted stock vesting lot 558 shares vesting on 01/27/2024

Restricted stock vesting lot 557 shares vesting on 04/27/2024

Restricted stock vesting lot 1,158 shares vesting on 10/11/2024

Key Terms

Restricted Stock Vesting, Aggregate proceeds, Form 144

3 terms

Restricted Stock Vesting financial

"01/27/2024 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Aggregate proceeds financial

"Howard Slayen ... 25000 | 2125000.00"

Form 144 regulatory

"CONTENT METADATA ... "form_type": "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6819	714119.78	31453254	05/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2024	Restricted Stock Vesting	Issuer			558	01/27/2024	Compensation
Common	04/27/2024	Restricted Stock Vesting	Issuer			557	04/27/2024	Compensation
Common	07/27/2024	Restricted Stock Vesting	Issuer			558	07/27/2024	Compensation
Common	10/11/2024	Restricted Stock Vesting	Issuer			1158	10/11/2024	Compensation
Common	10/27/2024	Restricted Stock Vesting	Issuer			557	10/27/2024	Compensation
Common	01/11/2025	Restricted Stock Vesting	Issuer			1158	01/11/2025	Compensation
Common	01/27/2025	Restricted Stock Vesting	Issuer			558	01/27/2025	Compensation
Common	04/11/2025	Restricted Stock Vesting	Issuer			1158	04/11/2025	Compensation
Common	04/27/2025	Restricted Stock Vesting	Issuer			557	04/27/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Howard Slayen 400 Kato Terrace Fremont CA 94539	Common	04/17/2026	25000	2125000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did AEHR insider Howard Slayen report on Form 144?

The filing reports a disposition of 25,000 shares of AEHR Common Stock sold on 04/17/2026 for aggregate proceeds of $2,125,000.00. The form lists the sale as a completed transaction under the disclosure rules.

Does the Form 144 show other share events for AEHR?

Yes, the filing lists multiple Restricted Stock Vesting entries dated between 01/27/2024 and 04/27/2025 with small lot sizes (e.g., 557, 558, 1158 shares). These entries appear as vesting disclosures.

How much did Howard Slayen receive from the reported sale?

The aggregate amount reported for the sale is $2,125,000.00 tied to the 25,000-share disposition on 04/17/2026. The filing provides this single aggregate proceeds figure for the transaction.

Is timing or a trading plan mentioned in the filing?

The provided excerpt does not state whether the sale was made pursuant to a trading plan or other arrangement. The filing shows the execution date and proceeds but no statement about pre-arrangement or plan status.

Where were the sold shares held prior to the transaction?

The filing identifies Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield RI as the broker/depository context for securities but does not explicitly state the insider’s prior beneficial-holding vehicle in the excerpt.